WARNING: WORLD CLASS ANALYSIS POST I’m only half a

New Post Public Reply Private Reply Replies (4) Message Board
Respert24
1,035
WARNING: WORLD CLASS ANALYSIS POST

I’m only half a bottle of St. Francis Cabernet into the evening so I’ll apologize in advance if this makes more sense than normal.

I got the latest SEC filing straight to my inbox earlier. Felt good. Hit it right in the sweet spot.

Then, like I do every time I get an email about a new filing I rush to open it up on my phone (which is what I’m usually on when these hit) and immediately start pretending like I know what the hell I’m looking at.

“Hmmm, yeah, yeah, definitely good stuff here”, I say to myself as I have to constantly zoom in and out on the 2pt font to see what the hell it says. “Must be related to the uplisting.”

Then I rush over here to see what people who aren’t me say. If it’s close to what I was guessing I get very impressed with myself.

Anyways, let’s talk about tomorrow!

Many of you haven’t been made aware (wine-induced sarcasm*) but there are a couple upcoming events related to our investments in CYDY. Tomorrow there will be a conference call to discuss updates related to ongoing efforts toward approval. Also, by the end of the month we’ll all need to vote on whether or not to sprinkle more gold on the already Scrooge McDuck-sized pool of coins at the executive gym down the street from the home office. They spray hospital grade sanitizer on the coins in between each board of director’s swim, so it’s safe. Not that they couldn’t just pull out the leronlimab vial they each carry in their suit pockets and self-inject themselves back to 100%, but you can never be too safe.

*Medical Term

(2/3rds of a bottle)

It’s probably a good idea to assume nothing good is going to come of the call so that you’re impressed when it’s over rather than disappointed.

Oh me?

I think we’re going to get something substantial.

I ran a binomial reduction of possibilities, cross referenced those against a standard Kruskal Wallis test (Thanks Google!), and then input those values into my premier league simulation software to check the results. My striker, Respert (Number 24, obviously) led the league in goals and had just nutmegged a defender when my computer screen went blue and asked if I wanted to restart in safe mode. So I think it’s “safe” to say that we’re totally going to get a major announcement tomorrow.

But what will it be?

Well, you heard it here first that…

I honestly don’t know.

But...BUT...I think we actually do get an announcement of the UK advancing Leronlimab toward approval. Something that becomes trackable and imminent. Maybe NASDAQ happens on the call, too. But regardless of the exact announcement I believe we will get something substantial toward approval and revenue. And if we don’t get anything negative (like the US or the UK declining to give us EUA, or NASDAQ telling us to shove it) we should be happy that after 30-ish days waiting on approval we haven’t been told no. That in and of itself should be a glaring positive that it’s going to get done. 30 days seems to be the reasonable timeframe for a decision. Why wait that long just to say no?

At any rate, I’m sick and tired of waiting like the rest of you. Beach houses don’t buy themselves and until I give the wife a beach house to decorate I’m stuck getting the investing equivalent of blue balls every time I wake up at 5:15 and stare at my phone until 6:00 for no PR. But as long as there isn't a roadblock thrown our way tomorrow I'll be happy. Progress is important.

(Full bottle complete)

In conclusion, now that I’m out of wine, I wish I had more facts, advice, and actionable information for you but I don’t. Just a little guess and a whole lot of fluff. Though I will predict that once we get approval we will see both an immediate jump in share price AND a steady move higher as more and more people learn about CYDY from the resulting news and jump onboard. So if you see it jump to, say, $19 with the news on the first day, I would predict that over the next 3-5 days there’s another significant increase as awareness spreads. This is why it will be difficult for me to know for sure when I pull out a small percentage of my shares to cover my initial investment or fund a pool. Not to mention that any approval brings the increased chances that all the other possibilities are more realistic than where they stand today, and that’s worth something too.

I’ll probably drink another bottle of wine tomorrow night after the call. Maybe I’ll post. I guess the question is, will it be a $15-$20 bottle of wine or a much more expensive one?

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PRG Projects' London Studio Elevates Live Entertainment

Updated Category News Views 110

A New Stage for Creativity in London When the curtain rises on a fresh idea, it's often the unknowns that make or break a production. Now, with PRG Projects unveiling their spanking new Project Studio in London, the tech and creative worlds might just bridge their gap tighter than a stage curtain before showtime. London Welcomes PRG's Innovative Hub This isn't just...

Continue Reading
Millions Tune In to 'Dedicate' Premiere in Manila

Updated Category News Views 242

Gathering for a New Kind of Celebration With a buzz louder than a crowded trading floor on a bull day, folks are flocking to catch the ripple effect of "Dedicate." Over 2 million views already, and it hasn't even hit the major radar yet—that's some serious fire in the storytelling world. The premiere in Manila, held at the Missionary Training Center (MTC), was no small...

Continue Reading
TalentNeuron Enhances Workforce Planning with New Tools

Updated Category News Views 49

A Game Changer for Workforce Strategy You ever get the feeling businesses treat workforce planning like a jigsaw puzzle, except the pieces change shape daily? Well, TalentNeuron's out here flipping the table by introducing some fancy new capabilities that'll make those pieces fit a whole lot easier. Yeah, it's about time someone thought to merge continuous workforce...

Continue Reading
Emergys and Glean Rearrange AI Puzzle for Enterprises

Updated Category News Views 30

Enterprises on AI: From Dreams to Doing Alright, here’s a nugget for you: AI isn't just pie-in-the-sky jazz anymore. Some folks are finally bringing it down to Earth. Emergys, a player in digital transformation, is shaking hands with Glean, renowned for their enterprise AI chops, to turn enterprise chaos into clarity. It's all about squeezing out real returns and...

Continue Reading
PRA Group Marks 30 Years with Nasdaq Bell Ringing

Updated Category News Views 0

A Milestone in Times Square Thirty trips around the sun, and here we are: PRA Group, the change-maker in the world of nonperforming loans, is celebrating by ringing the Nasdaq Opening Bell. It's a pretty big to-do in the financial world to get this nod, standing out in New York City's Times Square, no less. This shindig showcased Martin Sjolund, their President and CEO,...

Continue Reading
Abbott's SonicForce Impresses in Crucial Clinical Trial

Updated Category News Views 285

Breaking Through Cardiac Barriers Never thought I'd see the day when we're literally sending shockwaves through the heart, but here we are. Abbott's makin' waves, quite literally, with its SonicForce™ Coronary Intravascular Lithotripsy (IVL) System. They’ve just dropped some promising 30-day outcomes from the TECTONIC study, which has grabbed the spotlight at the...

Continue Reading
Virginia Innovation Boosts Startups and Research Growth

Updated Category News Views 0

Virginia's Rising Innovation Ecosystem Virginia, a place you might not expect to hear much about in terms of innovation, is actually shaking things up and making waves on a national scale. Throwing their hat into the innovation arena, Virginia's landed itself a cozy #5 spot for its 'Innovation and Research Ecosystem,' according to Area Development's latest rankings. The...

Continue Reading
IntelliGenome Partners with NL Diagnóstica for TB Battle

Updated Category News Views 102

Breaking New Ground in Tuberculosis Detection When IntelliGenome, a Houston-based developer of CRISPR-based diagnostic tech, teams up with São Paulo's veteran player NL Diagnóstica, you know they're onto something game-changing. This partnership is all about taking the fight against tuberculosis in Brazil to new heights with their CRISPR-Dx™ diagnostic platform. Not...

Continue Reading
Deferred Maintenance: Hidden Costs for Property Owners

Updated Category News Views 45

The Trap of Short-Term Savings Hoping to save a penny today could cost a dollar tomorrow, especially for commercial property owners choosing to delay necessary repairs. Courtenay Brack, a commercial property management guru from Charleston, South Carolina, lays it all out in a HelloNation article addressing this very issue. The Real Cost of Deferring Repairs Delaying...

Continue Reading
Lung Cancer Awareness Month: United for Progress

Updated Category News Views 25

A Concerted Effort for Lung Cancer Awareness Picture this: communities nationwide rallying together, not just to remember but to act against lung cancer. That's exactly what's happening this November, as LUNGevity Foundation spearheads Lung Cancer Awareness Month (LCAM). It’s not just about recognition—it's action with purpose. Driving Change Through Action This...

Continue Reading

Top 5 Most Recently Viewed Articles

Commercial Metals Company to Raise Funds for New Mill Project

Updated Category News Views 138

Commercial Metals Company Seeks Financing for Innovative Project Commercial Metals Company (NYSE: CMC) is embarking on an opportunistic move to secure $150 million in tax-exempt bond financing aimed at supporting its new mill project. This financing initiative has been authorized by the West Virginia Economic Development Authority (WVEDA), which will oversee the issuance...

Continue Reading
Sila Realty Trust Reveals Key Details on Earnings Release

Updated Category News Views 127

Sila Realty Trust Shares Earnings Release Schedule Sila Realty Trust, Inc. (NYSE: SILA) has exciting news as it gears up for its upcoming financial results. The company plans to issue its fourth quarter and yearly results after the trading day ends on the New York Stock Exchange on February 25, 2025. This announcement underscores Sila's commitment to transparency and...

Continue Reading
Understanding Recent Fluctuations in Upstart Holdings Stock

Updated Category News Views 180

Why Upstart Holdings, Inc. Is Facing Declines in Stock Value On a challenging trading day, shares of Upstart Holdings, Inc. (NASDAQ: UPST) have experienced a significant drop after the company shared its latest earnings report. This report included a combination of positive and disappointing earnings, which has contributed to mixed reactions among investors. Mixed...

Continue Reading
FanRoom LIVE's Star-Studded Season: A New Era Begins

Updated Category News Views 629

Exciting New Season for FanRoom LIVE FanRoom LIVE has officially launched its 2025 season, showcasing an impressive lineup of star-studded guests and engaging events that delight millions of fans. This season kicked off with Cara Buono, renowned for her role in STRANGER THINGS, participating in a highly anticipated Virtual Meet & Greet. Together with the show's...

Continue Reading
BCE's Strategic Move to Acquire Ziply Fiber Sparks Market Shift

Updated Category News Views 27

BCE's Strategic Move with Ziply Fiber Acquisition BCE, Inc. stock is experiencing a downward trend following a significant announcement regarding its subsidiary, Bell Canada. The company has entered into a definitive acquisition agreement to take over Ziply Fiber, a strategic decision that comes with a price tag of approximately $3.65 billion. Details of the Acquisition...

Continue Reading